A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER TRIAL OF SYSTEMIC FLUNISOLIDE IN THE TREATMENT OF CHILDREN WITH SEVERE ATOPIC-DERMATITIS